ELOX
Closed
Eloxx Pharmaceuticals Inc
0.0001
0.0000 (0.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.0001
Day's Range: 0.0001 - 0.0001
Send
sign up or login to leave a comment!
When Written:
2.51
Eloxx Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that is focused on developing novel treatments for genetic diseases caused by nonsense mutations. The company's lead product candidate, ELX-02, is a small molecule drug designed to restore the production of full-length functional proteins in patients with nonsense mutation-mediated diseases. Eloxx is also developing a pipeline of other novel therapies for genetic diseases, including cystic fibrosis, Usher syndrome, and Rett syndrome. The company was founded in 2013 and is headquartered in Waltham, Massachusetts. Eloxx Pharmaceuticals went public in 2018 and is traded on the NASDAQ exchange under the ticker symbol "ELOX."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








